Popular Posts Last 7 days_$type=three$meta=0$snip=0$rm=0$count=9$show=/search/label/Popular

Popular Posts Last 30 days_$type=three$meta=0$snip=0$rm=0$count=9$show=/search/label/Popular

Popular Posts Last year_$type=three$meta=0$snip=0$rm=0$count=9$show=/search/label/Popular

Popular Posts All time_$type=three$meta=0$snip=0$rm=0$count=9$show=/search/label/Popular

Islamophobia_$type=carousel$h=350$show=/search/label/Muslim%20World

Saudi Arabia$type=two$count=2$h=250$space=1$icon=1$m=0$sn=0$rm=0$show=/search/label/Muslim%20World

Iran_$type=three$count=3$h=250$space=1$icon=1$m=0$sn=0$rm=0$show=/search/label/Muslim%20World

Palestine$type=three$author=hide$comment=hide$rm=hide$date=hide$show=/search/label/Muslim%20World

Drug gives lung cancer patients four extra months

SHARE:

PARIS - Most lung cancer patients survived four months longer on an immunotherapy drug than those treated with chemotherapy, according to trial results published on Monday.

Importantly, they also experienced fewer side-effects, researchers reported in The Lancet medical journal.

Patients with non-small-cell lung cancer -- which represents by far the majority -- survived for 13.8 months on average on the drug called atezolizumab, compared to 9.6 months for those on chemotherapy, the study authors said.

And the difference was likely even bigger, as several participants on chemotherapy were given immunotherapy after the trial ended, possibly boosting their survival.

"Atezolizumab reinvigorates patients' immune systems against cancer," the study's lead author Achim Rittmeyer of the University of Goettingen in Germany, said in a statement.

"Our trial has shown that this has significant results for their survival."

Lung cancer is the most common cancer, affecting some 1.8 million people in the world every year, said Rittmeyer.

It is also the leading cause of cancer death in the world.

According to the American Cancer Society, 80-85 percent of lung cancers are non-small-cell types.

The trial recruited 850 patients without any remaining treatment options, and compared how long they survived -- half on atezolizumab and the rest on chemotherapy, the standard treatment.

Immunotherapy trains people's immune systems to attack tumour cells without killing healthy cells.

Chemotherapy, in contrast, targets all fast-dividing cells in the body, good and bad alike.

Unlike viruses or bacteria, cancer cells are not intruders but our own cells gone haywire, which explains why they circulate undisturbed by the immune system.

Still in its infancy, immunotherapy -- including atezolizumab -- is being tested on many cancer types.

In October, America's Food and Drug Administration fast-tracked atezolizumab for the treatment of patients with non-small-cell lung cancer.

"The time in which chemotherapy will no more be the mainstay of treatment of metastatic non-small-cell lung cancer is perhaps not so far away," Elisabeth Quoix of France's Strasbourg University Hospital wrote in a comment on the study, also carried by The Lancet.

COMMENTS

Name

Ads,5,Afghanistan,67,Africa,17,Americas,4,Animals,36,Asia,178,Australia,9,Austria,3,Bahrain,2,Bangladesh,15,Barcelona,1,Belgium,3,Brunei,1,Business,1225,Canada,2,Catalan,80,China,110,Cuba,3,Egypt,21,Europe,204,Fitness,14,France,22,Germany,32,Headlines,11,Health,168,Hillary Clinton,199,Hong Kong,1,Hungary,1,Iceland,1,India,99,Indonesia,8,International,75,Iran,74,Iraq,69,Ireland,2,Islamophobia,19,Israel,8,Italy,2,Japan,26,Jordan,1,Kenya,5,Kosovo,1,Kuwait,3,Lebanon,2,Libya,2,Lifestyle,301,Lithuania,1,Malaysia,12,Malta,1,Maxico,3,Middle East,109,Muslim World,567,Myanmar,31,Nawaz Sharif,5,Nepal,3,Netherlands,2,New Zealand,8,Niger,1,Nigeria,1,Nobel Prize,81,North Korea,47,Norway,1,Opinion,26,Pakistan,1016,Palestine,35,Philippine,11,Pics,66,Poland,2,Popular,1,Qatar,93,Rohingya,118,Russia,36,Rwanda,1,Saudi Arabia,80,Science,144,Serbia,2,Showbiz,346,Somalia,4,South Africa,1,South Korea,5,Spain,48,Sports,1287,Sudan,1,Sweden,1,Switzerland,2,Syria,104,Taiwan,2,Technology,437,Thailand,4,Today IN History,19,Top News,980,Tunisia,1,Turkey,72,U.S.,260,UAE,21,UK,44,Ukrain,2,Venezuela,4,Videos,75,Vietnam,2,World,4657,Yemen,21,
ltr
item
Muslim Global: Drug gives lung cancer patients four extra months
Drug gives lung cancer patients four extra months
https://4.bp.blogspot.com/-GyeivrmnWCQ/WE-OLve1dMI/AAAAAAAAWr8/yYFyMSNbfK8dSxGXNxFA5YabcK6TZ9whwCLcB/s640/Lung%2Bcancer.jpg
https://4.bp.blogspot.com/-GyeivrmnWCQ/WE-OLve1dMI/AAAAAAAAWr8/yYFyMSNbfK8dSxGXNxFA5YabcK6TZ9whwCLcB/s72-c/Lung%2Bcancer.jpg
Muslim Global
http://www.muslimglobal.com/2016/12/drug-gives-lung-cancer-patients-four.html
http://www.muslimglobal.com/
http://www.muslimglobal.com/
http://www.muslimglobal.com/2016/12/drug-gives-lung-cancer-patients-four.html
true
616431133175714168
UTF-8
Loaded All Posts Not found any posts VIEW ALL Readmore Reply Cancel reply Delete By Home PAGES POSTS View All RECOMMENDED FOR YOU LABEL ARCHIVE SEARCH ALL POSTS Not found any post match with your request Back Home Sunday Monday Tuesday Wednesday Thursday Friday Saturday Sun Mon Tue Wed Thu Fri Sat January February March April May June July August September October November December Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec just now 1 minute ago $$1$$ minutes ago 1 hour ago $$1$$ hours ago Yesterday $$1$$ days ago $$1$$ weeks ago more than 5 weeks ago Followers Follow THIS CONTENT IS PREMIUM Please share to unlock Copy All Code Select All Code All codes were copied to your clipboard Can not copy the codes / texts, please press [CTRL]+[C] (or CMD+C with Mac) to copy